Streetbeat News

Products Services

BMEA

Biomea Fusion will present data from its ongoing Phase II trial, COVALENT-111, evaluating BMF-219 in patients with Type 2 diabetes at the American Diabetes Association (ADA) 2023 conference.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 8:31 pm

LMDX

LumiraDx has received approval from the UK's CTDA for its COVID Ultra and COVID & RSV tests, which will allow the company to market and sell these products in the UK.

Portfolio Pulse from Bill Haddad

June 20, 2023 | 8:16 pm

QGEN

The FBI has approved QIAGEN's NGS-based ForenSeq MainstAY Workflow for the U.S. National DNA Index System. This will allow forensic laboratories to use the technology for DNA analysis in criminal investigations.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 8:11 pm

AMD

SMCI

Supermicro introduces MicroCloud, a high-density 3U 8-node system utilizing AMD Ryzen Zen 4 7000 Series processors. The new server provides a scalable solution for eCommerce, cloud gaming, software development, content creation, and private server instances.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 8:11 pm

EXAS

Exact Sciences Corp. announced that its Cologuard test demonstrated a 94% sensitivity for colorectal cancer at 91% specificity. This positive result may boost the company's reputation and demand for its product.

Portfolio Pulse from Bill Haddad

June 20, 2023 | 8:09 pm

LVRO

Lavoro Limited (NASDAQ:LVRO) announced a partnership with German agriculture innovator Stenon to offer real-time soil analyses to its customers in Latin America. The FarmLab tool measures soil parameters such as nitrogen, phosphorus, and magnesium, enabling precise identification of chemical elements necessary for plant growth and yield optimization.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 8:09 pm

ZVSA

Zyversa Therapeutics announced a publication in the Journal of the American Heart Association, linking NLRP3 inflammasomes with calcification in arteries of patients with peripheral arterial disease.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 8:08 pm

ICU

SeaStar Medical has enrolled its first patient in the NEUTRALIZE-AKI pivotal clinical trial to evaluate the safety and efficacy of its Selective Cytopheretic Device (SCD) extracorporeal therapy in adults with acute kidney injury (AKI) requiring continuous kidney replacement therapy (CKRT). The trial follows the resolution of a supply-chain issue.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 8:08 pm

PODD

Insulet Corporation has announced the commercial launch of its Omnipod 5 Automated Insulin Delivery System for individuals aged two years and older with type 1 diabetes in the United Kingdom. The Omnipod 5 System integrates with the Dexcom G6 Continuous Glucose Monitoring System to automatically adjust insulin delivery and help protect against high and low glucose levels. Insulet plans to release Omnipod 5 in Germany in the fall of 2023.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 8:02 pm

WSM

Williams Sonoma has collaborated with floral designer Jeff Leatham to launch a new collection of faux florals, combining Leatham's artistic vision and contemporary designs with Williams Sonoma's commitment to quality and style.

Portfolio Pulse from Benzinga Newsdesk

June 20, 2023 | 8:02 pm